Based on these premises, and trying to filling the knowledge gap in this filed, the aim of this study was to assess circulating levels of LBP and EndoCab IgM (markers of MT), IL-6 (marker of inflammation), I-FABP and Zonulin (markers of ID) in a cohort of SSc patients and healthy controls (HC). This evidence concerns the gene FABP2 and systemic sclerosis.